Simultaneous 18F-fluciclovine Positron Emission Tomography and Magnetic Resonance Spectroscopic Imaging of Prostate Cancer | Zendy

Morteza Esmaeili | Zendy; Nassim Tayari | Zendy; Tom W. J. Scheenen | Zendy; Mattijs Elschot | Zendy; Elise Sandsmark | Zendy; Helena Bertilsson | Zendy; Arend Heerschap | Zendy; Kirsten M. Selnæs | Zendy; Tone F. Bathen | Zendy

Open Access

Simultaneous 18F-fluciclovine Positron Emission Tomography and Magnetic Resonance Spectroscopic Imaging of Prostate Cancer

Author(s) -

Morteza Esmaeili,

Nassim Tayari,

Tom W. J. Scheenen,

Mattijs Elschot,

Elise Sandsmark,

Helena Bertilsson,

Arend Heerschap,

Kirsten M. Selnæs,

Tone F. Bathen

Publication year - 2018

Publication title -

frontiers in oncology

Language(s) - English

Resource type - Journals

SCImago Journal Rank - 1.834

H-Index - 83

ISSN - 2234-943X

DOI - 10.3389/fonc.2018.00516

Subject(s) - medicine , prostate cancer , positron emission tomography , magnetic resonance spectroscopic imaging , magnetic resonance imaging , nuclear medicine , cancer , creatine , prostatectomy , radiology

Purpose: To investigate the associations of metabolite levels derived from magnetic resonance spectroscopic imaging (MRSI) and 18 F-fluciclovine positron emission tomography (PET) with prostate tissue characteristics. Methods: In a cohort of 19 high-risk prostate cancer patients that underwent simultaneous PET/MRI, we evaluated the diagnostic performance of MRSI and PET for discrimination of aggressive cancer lesions from healthy tissue and benign lesions. Data analysis comprised calculations of correlations of mean standardized uptake values (SUV mean ), maximum SUV (SUV max ), and the MRSI-derived ratio of (total choline + spermine + creatine) to citrate (CSC/C). Whole-mount histopathology was used as gold standard. Results: The results showed a moderate significant correlation between both SUVmean and SUVmax with CSC/C ratio. Conclusions: We demonstrated that the simultaneous acquisition of 18 F-fluciclovine PET and MRSI with an integrated PET/MRI system is feasible and a combination of these imaging modalities has potential to improve the diagnostic sensitivity and specificity of prostate cancer lesions.

The content you want is available to Zendy users.

Already have an account? Click here to sign in.

Having issues? You can contact us here

Accelerating Research